Posted by
Estimates of Adult Benzodiazepine Use Double

Estimates of Adult Benzodiazepine Use Double

Baby boomers match seniors in the use of benzodiazepines, while misuse is most common in those aged 18 to 25. Over 30 million U.S. adults took benzodiazepines in the past year, including 5.3 million who misused the medication, according to a study posted December 17, 2018, in Psychiatric Services in Advance. The findings, which were based […]

Posted by
How Pharmacogenomics Can Help Patients with Treatment-Resistant Depression

How Pharmacogenomics Can Help Patients with Treatment-Resistant Depression

Treatment-resistant depression can be a frustrating challenge for doctor and patient alike. The trial-and-error process of trying different medications and treatments to see what alleviates patients’ depression symptoms can feel like a “shot in the dark” approach. According to Ann McDonald, former editor of the Harvard Mental Health Letter, in her blog post on the Harvard […]

Posted by
House Votes to Repeal Obamacare Tax Once Seen as Key to Health Law

House Votes to Repeal Obamacare Tax Once Seen as Key to Health Law

By Abby Goodnough WASHINGTON — In the heat of the legislative fight over the Affordable Care Act, Obama administration officials argued that including a steep tax on high-cost, generous health insurance plans was critical to the law because it would hold down soaring costs while helping to pay for its expanded health benefits. On Wednesday, that […]

Posted by
Ketamine-like drug for depression could get UK licence within the year

Ketamine-like drug for depression could get UK licence within the year

Esketamine could initially become available through private clinics but potential side effects raise concerns. A ketamine-like drug that could be licensed in the UK as soon as November could transform treatment for severe depression, one of the country’s leading psychiatrists has said. The drug, called esketamine, which is administered through a nasal spray, would be […]

Posted by
Treatment of fibromyalgia in adults not responsive to initial therapies

Treatment of fibromyalgia in adults not responsive to initial therapies

INTRODUCTION Fibromyalgia is a chronic pain disorder that is often difficult to treat. Effective interventions include a number of nonpharmacologic and pharmacologic therapies that are often provided in combination. Patients with fibromyalgia generally respond best to a multidisciplinary, individualized treatment program that incorporates the primary treating clinician and other healthcare providers, including physical medicine, rehabilitation, […]

Posted by
Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder

Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder

Aimee M. HunterMichael J. MinzenbergIan A. CookDavid E. KrantzJennifer G. LevittNatalie M. RotsteinShweta A. ChawlaAndrew F. LeuchterFirst published: 02 April 2019 https://doi.org/10.1002/brb3.1275 Cited by: 1 Abstract Background Repetitive Transcranial Magnetic Stimulation (rTMS) is commonly administered to Major Depressive Disorder (MDD) patients taking psychotropic medications, yet the effects on treatment outcomes remain unknown. We explored how concomitant medication use relates […]

Posted by
Cannabis: Doctors tell FDA to get out of the weeds

Cannabis: Doctors tell FDA to get out of the weeds

Publish date: May 31, 2019 By Kari Oakes  Clinical Neurology News FROM AN FDA PUBLIC HEARING The Food and Drug Administration held its first-ever public hearing about products containing cannabis or cannabis-derived compounds – and it got an earful. Hearing from over 100 individuals, the all-staff FDA panel was asked repeatedly to take the lead in bringing order […]